Stealth BioTherapeutics Corp. ADS - ADR

Name: Stealth BioTherapeutics Corp. ADS - ADR Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Stealth BioTherapeutics Corp. ADS - ADR

Stock Card

$0.32

$0.00 (0.00%)

As on 16-Nov-2022 09:30EDT

Market cap

$24 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

36.6

Div. Yield

0 %

Stealth BioTherapeutics Corp. ADS - ADR Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 0.32 High: 0.32

52 Week Range

Low: -- High: --

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$-45 Mln
ROE

-16.7 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-0.1
Debt to Equity

-0.3
Book Value

$--
EPS

$-0.9
Face value

--
Shares outstanding

73,548,600

6 Years Aggregate

CFO

$-342.43 Mln

EBITDA

$-374.13 Mln

Net Profit

$-422.38 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Stealth BioTherapeutics Corp. ADS - ADR	-61.4	1.6	2.9	-68.3	-66.7	--	--
BSE Sensex^*	-9.6	-2.7	2.9	-5.0	5.4	5.7	10.4
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 16-Nov-2022 | *As on 04-Sep-2026 | #As on 26-Oct-2023

Company	2021	2020
Stealth BioTherapeutics Corp. ADS - ADR	-44.5	-54.1
S&P Small-Cap 600	25.3	9.6
BSE Sensex	22.0	15.8

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Shareholding Pattern

View Details

About Stealth BioTherapeutics Corp. ADS - ADR

Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate is Elamipretide that is in... phase 3 clinical trial to treat barth syndrome, phase 2/3 clinical trial for the treatment of duchenne cardiomyopathy, phase 2a clinical trial to treat friedreich's ataxia, phase 2 clinical trial for the treatment of dry age-related macular degeneration, phase 2 clinical trial to treat leber's hereditary optic neuropathy, and phase 3 clinical trial for the treatment of replisome myopathies. The company's product candidates also include SBT-20 to treat complications of diabetes, renal diseases, ocular diseases, neurodegenerative, Parkinson's, Alzheimer's, Huntington's, and ALS diseases; SBT-550 for rare neurological indications; and SBT-272, a peptidomimetic that targets the mitochondria and stabilizing mitochondrial function under conditions of oxidative stress, as well as SBT 550. Stealth BioTherapeutics Corp was incorporated in 2006 and is based in George Town, the Cayman Islands. Read more

Pres ,CEO, Sec. & Director

Ms. Irene P. McCarthy J.D.
Pres ,CEO, Sec. & Director

Ms. Irene P. McCarthy J.D.
Headquarters

George Town
Website

https://www.stealthbt.com

FAQs for Stealth BioTherapeutics Corp. ADS - ADR

What is the current share price of Stealth BioTherapeutics Corp ADS - ADR Today?

The share price of Stealth BioTherapeutics Corp ADS - ADR is $0.32 (NASDAQ) as of 16-Nov-2022 09:30 EDT. Stealth BioTherapeutics Corp ADS - ADR has given a return of -66.67% in the last 3 years.

What is the current PB & PE ratio of Stealth BioTherapeutics Corp ADS - ADR?

Since, TTM earnings of Stealth BioTherapeutics Corp ADS - ADR is negative, P/E ratio is not available.
The P/B ratio of Stealth BioTherapeutics Corp ADS - ADR is 36.57 times as on 16-Nov-2022, a 637 premium to its peers’ median range of 4.96 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2021	-0.90	-1.04
2020	-1.20	-6.63
2019	-1.41	5.85
2018	--	--
2017	--	--

What is the 52 Week High and Low of Stealth BioTherapeutics Corp ADS - ADR?

The 52-week high and low of Stealth BioTherapeutics Corp ADS - ADR are Rs -- and Rs -- as of 06-Sep-2026.

What is the market cap of Stealth BioTherapeutics Corp ADS - ADR?

Stealth BioTherapeutics Corp ADS - ADR has a market capitalisation of $ 24 Mln as on 16-Nov-2022. As per SEBI classification, it is a Small Cap company.

Should I invest in Stealth BioTherapeutics Corp ADS - ADR?

Before investing in Stealth BioTherapeutics Corp ADS - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.